Prevention of heterotopic ossification after THA with indomethacin: Analysis of risk factors;Ossifikationsprophylaxe nach hüft-TEP mit indomethacin: Analyse von risikofaktoren

Zeitschrift fur Orthopadie und Ihre Grenzgebiete

Volumn 143, Issue 6, 2005, Pages 631-637

  Zehetgruber, Harald ^a   Grubl A ^a   Goll, A ^b   Schwameis, E ^c   Wurnig, C ^d   Giurea, A ^a  

^a University of Vienna   (Austria)

^b VIENNA UNIVERSITY OF ECONOMICS AND BUSINESS   (Austria)

^c Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^d Orthopadisches Spital Speising   (Austria)

Author keywords

Cementfree; Heterotopic bone; High risk; Hip arthroplasty; Indomethacin; Prospective; Short term

Indexed keywords

INDOMETACIN;

ADULT; AGE; AGED; ARTICLE; ECTOPIC TISSUE; FEMALE; HETEROTOPIC OSSIFICATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOARTHRITIS; RISK ASSESSMENT; RISK FACTOR; TOTAL HIP PROSTHESIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROPLASTY, REPLACEMENT, HIP; CAUSALITY; COMORBIDITY; FEMALE; GERMANY; HUMANS; INCIDENCE; INDOMETHACIN; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; PROSTHESIS-RELATED INFECTIONS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 29944440788     PISSN: 00443220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-918190     Document Type: Article

References (34)

1. Charnley J. The long-term results of low friction arthroplasty of the hip performed as a primary intervention. J Bone Joint Surg [Br] 1972; 54: 61-76
2. Rosendahl S, Christoffersen JK, Norgaard M. Paraarticular ossification following hip replacement. 70 arthroplasties ad modum Moore using McFarland's approach. Acta Orthop Scand 1977; 48: 400-404
3. Eyb R, Zweymüller K. Periartikuläre Ossifikationen nach Implantation zementfreier Hüfttotalendoprothesen vom Typ Zweymüller-Endler. Z Orthop 1985; 123: 975-980
4. Egli S, Woo A. Risk Faktors for heterotopic ossification in total hip arthroplasty. Arch Orthop Trauma Surg 2001; 121: 531-535
5. Kjaersgaard-Andersen P, Nafei A, Teichert G, Kristensen O, Schmidt SA, Keller J, Lucht U. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties. Acta Orthop Scand 1993; 64: 639-642
6. DeLee J, Ferrari A, Charnley J. Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop 1976; 121: 53-59
7. Nollen AJ, Slooff TJ. Paraarticular ossifications after total hip replacement. Acta Orthop Scand 1973; 44: 230-241
8. Jowsey J, Coventry M, Robins PR. Heterotopic Ossification: Theoretical considerations, possible etiological factors, and a clinical review of total hip artrhroplasty patients exhibiting this phenomenon. In: Murray WR (ed). The Hip: Proceedings of the 5th Open Scientific Meeting of the Hip Society. CV Mosby, St. Louis; 177: 201-222
9. Ritter MA, Vaughn RB. Ectopic ossification after total hip arthroplasty. J Bone Joint Surg [Am] 1977; 59: 345-351
10. Schmidt SA, Kjaersgaard-Andersen P, Pedersen NW. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized double-blind clinical trial. J Bone Joint Surg [Am] 1988; 70: 834-838
11. Pagnani MJ, Pellicci PM, Salvati EA. Effect of aspirin on heterotopic ossification after total hip arthroplasty in men who have osteoarthritis. J Bone Joint Surg [Am] 1991; 73: 924-929
12. Kjaersgaard-Andersen P, Ritter MA. Prevention of formation of heterotopic bone after total hip arthroplasty. J Bone Joint Surg [Am] 1991; 73: 942-947
13. Pellegrini VD Jr, Konski AA, Gastel JA, Rubin P, Evarts CM. Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field. J Bone Joint Surg [Am] 1992; 74: 186-200
14. Dahl HK. Clinical observations. Symposium on Arthrose. Proceedings of a Conference. October 1974, Norway 1976; 37-46
15. Wurnig C, Auersperg V, Boehler N. Short term prophylaxis against heterotopic bone after cement less hip replacement. Clin Orthop 1997; 334: 175-183
16. Fransen M, Neal B. Non steroidal ant-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev 2004; CD001160
17. Ritter MA, Gioe TJ. The effect of indomethacin on pararticular ectopic ossification following total hip arthroplasty. Clin Orthop 1982; 167: 113-117
18. Cella JP, Salvati EA, Sculco TP. Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects. J Arthroplasty 1988; 3: 229-234
19. Amstutz HC, Dorey FJ. Short-course Indomethacin prevents heterotopic ossfication in a High-risk Population after total hip arthroplasty. J Arthroplasty 1997; 12: 126-132
20. McMahon JS, Waddell JP, Morton J. Effect of short course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty. J Arthroplasty 1991; 6: 259-264
21. Wurnig C, Schwameis E, Bitzan P, Kainberger F. Six-Year results of a cementless stem with prophylaxis against heterotopic bone. Clin Orthop 1999; 361: 150-157
22. Knelles D, Barthel T, Karrer A, Kraus U, Eulert J, Kolbl O. Prevention of heterotopic ossification after total hip replacement. A prospective, randomized study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J Bone Joint Surg [Br] 1997; 79: 596-602
23. Ahrengart L, Lindgren U. Heterotopic bone after hip arthroplasty. Defining the patient at risk. Clin Orthop 1993; 293: 153-159
24. Riegler HF, Harris CM. Heterotopic bone formation after total hip arthroplasty. Clin Orthop 1976; 117: 209-216
25. Cornes PG, Shahidi M, Glees JP. Heterotopic bone formation: irradiation of high-risk patients. Br J Radiol 2002; 75: 448-452
26. Arcq M. Ectopic ossification, a complication after total hip replacement. Arch Orthop Unfallchir 1973; 77: 108-131
27. Kjaersgaard AP, Hougard K, Linde F. Heterotopic bone formation after total hip arthroplasty in patients with primary or secondary coxarthrosis. Orthopedics 1990; 13: 1211-1217
28. Bundrick TJ, Cook DE, Resnik CS. Heterotopic bone formation in patients with DISH following total hip replacement. Radiology 1985; 155: 595-597
29. Sundaram NA, Murphy JC. Heterotopic bone formation following total hip arthroplasty in ankylosing spondylitis. Clin Orthop 1986; 207: 223-226
30. Bauer R. Operative Approaches to Orthopaedic Surgery and Traumatology. Stuttgart, Thieme Verlag 1987
31. Zweymüller KA, Lintner F, Semlitsch M. Biologic fixation of a press-fit titanium hip joint endoprosthesis. Clin Orthop 1998; 235: 195-206
32. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures treatment by mold arthroplasty. An end result study using a new method of result evaluation. J Bone Joint Surg [Am] 1969; 51: 737-755
33. Brooker AF, Bowerman JW, Robinson RA, Riley LH. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg [Am] 1973; 55: 1629-1632
34. Jowsey J, Coventry MB. Heterotopic ossification: Theoretical considerations, possible etiological factors, and a clinical review of total hip arthroplasty patients exhibiting this phenomenon. Orthop Trans 1977; 1: 69-82